| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA4589671
Max Phase: Preclinical
Molecular Formula: C7H7NOS
Molecular Weight: 153.21
Molecule Type: Unknown
Associated Items:
Representations
Canonical SMILES: NCc1cc2occc2s1
Standard InChI: InChI=1S/C7H7NOS/c8-4-5-3-6-7(10-5)1-2-9-6/h1-3H,4,8H2
Standard InChI Key: MIBPQOWRFXVNFJ-UHFFFAOYSA-N
Associated Targets(Human)
Lysyl oxidase homolog 2 834 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 153.21 | Molecular Weight (Monoisotopic): 153.0248 | AlogP: 1.95 | #Rotatable Bonds: 1 |
| Polar Surface Area: 39.16 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
| #RO5 Violations: 0 | HBA (Lipinski): 2 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: | CX Basic pKa: 8.40 | CX LogP: 1.28 | CX LogD: 0.24 |
| Aromatic Rings: 2 | Heavy Atoms: 10 | QED Weighted: 0.68 | Np Likeness Score: -0.31 |
References
| 1. (2018) Lysyl oxidase-like 2 inhibitors and uses thereof, |
Source
Source(1):